FDA Builds Quality Dashboard To Focus CMC Reviews And Inspections On Greatest Risks

A dashboard tool US FDA is developing promises to liberate key information from the agency’s trove of CMC review documents, enabling greater consistency among reviews and a greater emphasis on the manufacturing issues that pose the greatest risks.